Spots Global Cancer Trial Database for mitoxantrone hydrochloride liposome

Every month we try and update this database with for mitoxantrone hydrochloride liposome cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma	NCT05575973	Diffuse Large B...	Mitoxantrone Hy... Rituximab Lenalidomide	60 Years - 75 Years	Huazhong University of Science and Technology
A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia	NCT05345938	Relapsed or Ref...	Mitoxantrone Hy...	18 Years -	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor	NCT05089461	Advanced Malign...	Mitoxantrone Hy...	18 Years -	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Study of Mitoxantrone Hydrochloride Liposome Infusion	NCT02856685	Non-Hodgkin's L...	Mitoxantrone Hy...	18 Years -	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma	NCT05784987	Diffuse Large B...	Rituximab Mitoxantrone hy... Isophosphamide Etoposide X: Orelabrutini... X: Chidamide X: Penpulimab X: Lenalidomide	18 Years - 75 Years	The First Affiliated Hospital with Nanjing Medical University
CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma	NCT06433362	Peripheral T Ce...	CMOEP	18 Years - 70 Years	Tianjin Medical University Cancer Institute and Hospital
Phase I Study of Mitoxantrone Hydrochloride Liposome Injection	NCT02131688	Malignant Lymph...	Mitoxantrone Hy...	18 Years - 70 Years	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors	NCT05620862	Pediatric Solid...	Mitoxantrone Hy... Irinotecan Vincristine	2 Years - 21 Years	Sun Yat-sen University
CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma	NCT06433362	Peripheral T Ce...	CMOEP	18 Years - 70 Years	Tianjin Medical University Cancer Institute and Hospital
Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection	NCT02043756	Neoplasms	Mitoxantrone Hy... Mitoxantrone	18 Years - 70 Years	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia	NCT05345938	Relapsed or Ref...	Mitoxantrone Hy...	18 Years -	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer	NCT06156761	Breast Cancer	Mitoxantrone hy... Capecitabine Mitoxantrone hy... Capecitabine	18 Years - 70 Years	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia	NCT05345938	Relapsed or Ref...	Mitoxantrone Hy...	18 Years -	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer	NCT06156761	Breast Cancer	Mitoxantrone hy... Capecitabine Mitoxantrone hy... Capecitabine	18 Years - 70 Years	Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: